182 related articles for article (PubMed ID: 12610802)
1. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis.
Cibere J; Deng Z; Lin Y; Ou R; He Y; Wang Z; Thorne A; Lehman AJ; Tsang IK; Esdaile JM
J Rheumatol; 2003 Mar; 30(3):465-7. PubMed ID: 12610802
[TBL] [Abstract][Full Text] [Related]
2. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study.
Tao X; Younger J; Fan FZ; Wang B; Lipsky PE
Arthritis Rheum; 2002 Jul; 46(7):1735-43. PubMed ID: 12124856
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
7. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Terán L; Galván-Villegas F; García-Figueroa J; Jara LJ; Barile L;
Arch Med Res; 2004; 35(1):36-42. PubMed ID: 15036798
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
[TBL] [Abstract][Full Text] [Related]
11. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.
Chopra A; Lavin P; Patwardhan B; Chitre D
J Rheumatol; 2000 Jun; 27(6):1365-72. PubMed ID: 10852255
[TBL] [Abstract][Full Text] [Related]
12. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study.
Kondo H; Abe T; Hashimoto H; Uchida S; Irimajiri S; Hara M; Sugawara S
J Rheumatol; 2004 Feb; 31(2):243-51. PubMed ID: 14760792
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial.
Li EK; Tam LS; Wong CK; Li WC; Lam CW; Wachtel-Galor S; Benzie IF; Bao YX; Leung PC; Tomlinson B
Arthritis Rheum; 2007 Oct; 57(7):1143-50. PubMed ID: 17907228
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
Tao X; Cush JJ; Garret M; Lipsky PE
J Rheumatol; 2001 Oct; 28(10):2160-7. PubMed ID: 11669150
[TBL] [Abstract][Full Text] [Related]
17. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Williams GW; Kivitz AJ; Brown MT; Verburg KM
Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
[TBL] [Abstract][Full Text] [Related]
18. Effects of clarithromycin in patients with active rheumatoid arthritis.
Ogrendik M
Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733
[TBL] [Abstract][Full Text] [Related]
19. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis.
Pillemer S; Gulko P; Ligier S; Yarboro C; Gourley M; Goldbach-Mansky R; Siegel R; Hirsch R; Pucino F; Tilley B; Wilder RL
J Rheumatol; 2003 Jan; 30(1):41-3. PubMed ID: 12508388
[TBL] [Abstract][Full Text] [Related]
20. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup.
Taylor WJ; Rajapakse CN; Harris KA; Harrison AA; Corkill MM
J Rheumatol; 1999 Dec; 26(12):2544-50. PubMed ID: 10606361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
